Tenet Healthcare Corporation THC
Set alert
268.89 USD -4.36 -1.60%
At close
268.89 0.00 0.00%
Pre-market · Nov 3, 4:05 AM ET
257.95 Day range 277.61
157.58 52-week range 283.05
- YTD
- +35.31%
- 1 year
- +30.22%
- Open
- 275.95
- Prev close
- 273.25
- Mkt cap
- 21.40B
- Vol
- 1.30M
- Avg vol
- 752.10K
- EPS
- 33.74
- P/E
- 7.97
- Div yield
- 0.00%
More statistics
- Low
- 257.95
- High
- 277.61
- Forward P/E
- 13.10
- Beta
- 1.20
- Short ratio
- 2.63
- Inst. own
- 103.12%
- Dividend
- 0.00
- Ex-div date
- Mar 12, 2000
- Earnings
- Feb 10, 2027
- 50-d avg
- 264.87
- 200-d avg
- 220.21
- 1y target
- 298.82
1M chart
Events in this range
- Oct 16, 2026Rating: Guggenheim · Buy → Buy
- Oct 29, 2026Earnings: 6.64; estimate 4.68; surprise 41.88%
- Oct 30, 2026Rating: Guggenheim · Buy → Buy
Signals (9)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 27, 2026 | 6 days ago |
| MACD: Sell Signal | Oct 27, 2026 | 6 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 1 month ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 298.82 +11.1% upside
Now 268.89
- Target (low)
- 265.00
- Target (mean)
- 298.82
- Target (high)
- 342.00
Ratings (0m) 23 19 buy · 4 hold · 0 sell
- Strong buy5
- Buy14
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 23
- 1 month ago 23
- 2 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 5.41 | 4.47 – 6.09 | 4.70 | +15.0% | 5.69B | +3.0% | 19 |
| Next quarter | 4.64 | 3.85 – 5.38 | 4.82 | -3.8% | 5.45B | +1.6% | 12 |
| Current year | 22.17 | 21.05 – 23.01 | 16.78 | +32.1% | 22.46B | +5.4% | 20 |
| Next year | 20.52 | 17.92 – 23.21 | 22.17 | -7.4% | 22.52B | +0.3% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Nov 2, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 2, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 16, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 23, 2026 | BMO Capital | Initiated | — | Market Perform |
| Sep 18, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 3, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 28, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 28, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 28, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 27, 2026 | UBS | Maintained | Buy | Buy |
| Jul 27, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 27, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 27, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 20, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 13, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 9, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 22, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 5, 2026 | Baird | Maintained | Neutral | Neutral |
| May 4, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| May 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 1, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 1, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Mar 12, 2026 | Guggenheim | Maintained | Buy | Buy |
| Mar 12, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Feb 20, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
